Nonhypoglycemic drug reactions of agents used to treat diabetes.
The different classes of agents now available for the treatment of diabetes, each with its own unique mechanism of action, present the clinician with numerous choices to achieve glycemic control. Therapy can be tailored for each patient. If the primary problem is insulin resistance, a thiazolidinedione can be used. The clinician should remember the potential adverse reactions of the drugs and their potential interaction with other conditions a patient may have. After this careful consideration, the optimal therapeutic regimen for a patient can be developed.
White
J A
JA
Harborview Medical Center, Seattle, Washington, USA.
Hirsch
I B
IB
D001549:Benzamides / Q000009:adverse effects; D001645:Biguanides / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000188:drug therapy*; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects; D013453:Sulfonylurea Compounds / Q000009:adverse effects; D013844:Thiazoles / Q000009:adverse effects
D001549:Benzamides; D001645:Biguanides; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D013844:Thiazoles; C030516:meglitinide